Small molecule ectonucleotidase inhibitors for the immunotherapy of cancer

被引：0
|
作者：
Muller, Christa [1 ,2 ]
机构：
[1] Univ Bonn, Pharmaceut Chem, Bonn, Germany
[2] PharmaCtr Bonn, Bonn, Germany
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
2
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
    Vigano, Mauro
    La Milia, Marta
    Grassini, Maria Vittoria
    Pugliese, Nicola
    De Giorgio, Massimo
    Fagiuoli, Stefano
    CANCERS, 2023, 15 (06)
  • [32] Progress towards orally bioavailable, potent, and selective small-molecule inhibitors of CD73 for cancer immunotherapy
    Lindsey, E.
    Lawson, K.
    Thomas-Tran, R.
    Beatty, J.
    Fournier, J.
    Mandal, D.
    Yan, X.
    Drew, S.
    Jeffrey, J.
    Walker, N.
    Straeter, N.
    Moschuetz, S.
    Chen, A.
    Tan, J.
    Jin, L.
    Walters, M.
    Young, S.
    Schindler, U.
    Leleti, M.
    Powers, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E93 - E93
  • [33] Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present)
    Nocentini, Alessio
    Capasso, Clemente
    Supuran, Claudiu T.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (10) : 867 - 876
  • [34] Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy
    Masci, Domiziana
    Puxeddu, Michela
    Silvestri, Romano
    La Regina, Giuseppe
    MOLECULES, 2024, 29 (09):
  • [35] Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
    Adderley, H.
    Blackhall, F. H.
    Lindsay, C. R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 589 - 595
  • [36] Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
    H. Adderley
    F. H. Blackhall
    C. R. Lindsay
    Cancer Immunology, Immunotherapy, 2021, 70 : 589 - 595
  • [37] High-affinity small molecule inhibitors of T cell costimulation: Compounds for immunotherapy
    Huxley, P
    Sutton, DH
    Debnam, P
    Matthews, IR
    Brewer, JE
    Rose, J
    Trickett, M
    Williams, DD
    Andersen, TB
    Classon, BJ
    CHEMISTRY & BIOLOGY, 2004, 11 (12): : 1651 - 1658
  • [38] A case for combining immunotherapy and targeted small molecule inhibitors: Immunoregulation by primary melanoma cells
    Maniyar, Rachana R.
    Chakraborty, Sanjukta
    Tuli, Neha Y.
    Ben Rahoma, Ghada
    Singh, Sarnath
    Wallack, Marc
    Geliebter, Jan
    Tiwari, Raj K.
    CANCER RESEARCH, 2018, 78 (13)
  • [39] Targeting the adenosine immunosuppressive pathway for cancer immunotherapy with small molecule agents
    Fons, Pierre
    Esquerre, Michael
    Versluys, Stephanie
    Mambrini, Gigliola
    Paillasse, Michael
    Bell, Andy
    Schreyer, Adrian
    Cox, Richard
    Bickerton, Richard
    Lisztwan, Joanna
    Whittaker, Mark
    Bono, Francoise
    Johnstone, Craig
    Hopkins, Andrew
    CANCER RESEARCH, 2017, 77
  • [40] Small molecule Bax activator enhances immunotherapy against lung cancer
    Anisuzzaman, Abu Syed Md
    Talukdar, Muhammad Waliul
    Deng, Xingming
    CANCER RESEARCH, 2023, 83 (07)
12345